Acinetobacter baumannii infections in a tertiary care Hospital in Mexico over the past 13 years

Chemotherapy

Volumn 59, Issue 1, 2013, Pages 57-65

  Morfin Otero, R ^a,b   Alcantar Curiel M D ^c   Rocha, M J ^c   Alpuche Aranda, C M ^c   Santos Preciado, J I ^c   Gayosso Vazquez C ^c   Araiza Navarro, J R ^b   Flores Vaca, M ^b   Esparza Ahumada, S ^a,b   Gonzalez Diaz E ^a,b   Perez Gomez H R ^a,b   Rodriguez Noriega E ^a,b  

^a HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acinetobacter baumannii; Antimicrobial susceptibility; Resistance patterns

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; TETRACYCLINE;

ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BLOOD; CEREBROSPINAL FLUID; DISK DIFFUSION; HUMAN; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC WARD; PLEURA FLUID; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL WARD; TEACHING HOSPITAL; TERTIARY CARE CENTER; URINE;

EID: 84879757511     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000351098     Document Type: Article

References (31)

1. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA: Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 3471-3484.
2. Peleg AY, Seifert H, Paterson DL: Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
3. Munoz-Price LS, Weinstein RA: Acinetobacter infection. N Engl J Med 2008; 358: 1271-1281.
4. de Benedictis FM, Osimani P, Gabriele C: Acinetobacter baumannii infections in children. Lancet Infect Dis 2010; 10: 143-144.
5. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS: Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 2010; 50: 1611-1616.
6. Shelburne SA 3rd, Singh KV, White AC Jr, Byrne L, Carmer A, Austin C, Graviss E, Stager C, Murray BE, Atmar RL: Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas. J Clin Microbiol 2008; 46: 198-205.
7. Runnegar N, Sidjabat H, Goh HM, Nimmo GR, Schembri MA, Paterson DL: Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol 2010; 48: 4051-4056.
8. van den Broek PJ, van der Reijden TJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L: Endemic and epidemic Acinetobacter species in a university hospital: an 8-year survey. J Clin Microbiol 2009; 47: 3593-3599.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
10. Hamouda A, Evans BA, Towner KJ, Amyes SG: Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes. J Clin Microbiol 2010; 48: 2476-2483.
11. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heers-ma H, Dijkshoorn L: Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
12. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
13. Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A: Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing. J Clin Microbiol 2002; 40: 2755-2759.
14. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y: Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40: 3798-3801.
15. Weisenberg SA, Schuetz AN, Alexander EA, Eiss B, Behta M, Saiman L, Larone DH, Jenkins SG, Rhee KY: Endemic Acinetobacter baumannii in a New York hospital. PLoS One 2011; 6:e28566.
16. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J: Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000; 31: 101-106.
17. D'Agata EM, Thayer V, Schaffner W: An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol 2000; 21: 588-591.
18. Ledizet M, Murray TS, Puttagunta S, Slade MD, Quagliarello VJ, Kazmierczak BI: The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patients. PLoS One 2012; 7:e49578.
19. Tilley PA, Roberts FJ: Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis1994; 18: 896-900.
20. Maslow JN, Glaze T, Adams P, Lataillade M: Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital. Infect Control Hospital Epidemiol 2005; 26: 69-75.
21. Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH, Ryu J, Kim YS: Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004; 48: 224-228.
22. Garza-Gonzalez E, Llaca-Diaz JM, Bosques-Padilla FJ, Gonzalez GM: Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii. Chemotherapy 2010; 56: 275-279.
23. Fukuta Y, Clarke LG, Shields RK, Wagener MM, Pasculle AW, Doi Y: Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complex. Infect Control Hosp Epidemiol 2012; 33: 1051-1052.
24. Fournier PE, Richet H: The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42: 692-699.
25. Apisarnthanarak A, Warren DK, Fraser VJ: Creating a cohort area to limit transmission of pandrug-resistant Acinetobacter baumannii in a Thai tertiary care center. Clin Infect Dis 2009; 48: 1487-1488.
26. Gonzalez-Chavez MI, Morfin-Otero R, Jarillo-Quijada C, Gayosso-Vazquez E, Rodriguez-Noriega E, Santos-Preciado JI, Giono-Cerezo S, Alpuche-Aranda CM, Alcantar-Curiel MD: First report of blavim-4, blaimp-1 and blaoxa-24-producing Acinetobacter baumannii clones isolated from nosocomial infections in Mexico (abstract C2-648). Abstracts of the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Ill., September 2011.
27. Gales AC, Castanheira M, Jones RN, Sader HS: Antimicrobial resistance among Gramnegative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012; 73: 354-360.
28. Esterly JS, Griffith M, Qi C, Malczynski M, Postelnick MJ, Scheetz MH: Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections. Antimicrob Agents Chemother 2011; 55: 4844-4849.
29. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-Wittel IM, Gallego-Lara SL, Madrazo-Osuna J: Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003; 36: 1111-1118.
30. Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E: Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 2008; 46: 567-570.
31. Fishbain J, Peleg AY: Treatment of Acinetobacter infections. Clin Infect Dis 2010; 51: 79-84.